Effect of adrenalectomy on the pancreas of db/db mice

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

The enzyme 11β–hydroxysteroid dehydrogenase (HSD) type 1 converts inactive cortisone into active cortisol in cells, thereby raising the effective glucocorticoid (GC) tone above serum levels. We report that pharmacologic inhibition of 11β-HSD1 has a therapeutic effect in mouse models of metabolic syndrome. Administration of a selective, potent 11β-HSD1 inhibitor lowered body weight, insulin, fasting glucose, triglycerides, and cholesterol in diet-induced obese mice and lowered fasting glucose, insulin, glucagon, triglycerides, and free fatty acids, as well as improved glucose tolerance, in a mouse model of type 2 diabetes. Most importantly, inhibition of 11β-HSD1 slowed plaque progression in a murine model of atherosclerosis, the key clinical sequela of metabolic syndrome. Mice with a targeted deletion of apolipoprotein E exhibited 84% less accumulation of aortic total cholesterol, as well as lower serum cholesterol and triglycerides, when treated with an 11β-HSD1 inhibitor. These data provide the first evidence that pharmacologic inhibition of intracellular GC activation can effectively treat atherosclerosis, the key clinical consequence of metabolic syndrome, in addition to its salutary effect on multiple aspects of the metabolic syndrome itself.

Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system

The basic hypothesis of this review is that studies on models of experimental obesity can provide insight into the control systems regulating body nutrient stores in humans. In this homeostatic or feedback approach to analysis of the nutrient control system, we have examined the afferent feedback signals, the central controller, and the efferent control elements regulating the controlled system of nutrient intake, storage, and oxidation. The mechanisms involved in the beginning and ending of single meals must clearly be related to the long-term changes in fat stores, although this relationship is far from clear. Changes in total nutrient storage in adipose tissue can arise as a consequence of changes in the quantity of nutrients ingested in one form or another or a decrease in the utilization of the ingested nutrients. A change in energy intake can be effected by increased size of individual meals, increased number of meals in a 24-hour period, or a combination of these events. Similarly, a decrease in utilization of these nutrients can develop through changes in resting metabolic energy expenditure which are associated with one of more of the biological cycles such as protein metabolism, triglyceride for glycogen synthesis and breakdown, or maintenance of ionic gradients for Na+ + K+ across cell walls. In addition, differences in energy expenditure related to the thermogenesis of eating or to the level of physical activity may account for differences in nutrient utilization.

Control of spontaneous glucose intolerance, hyperinsulinemia, and islet hyperplasia in nonobese C3H.SW male mice by Y-linked locus and adrenal gland

An inbred strain predisposition to maturity-onset impairment of glucose tolerance was discovered in C3H.SW/SnJ inbred male mice. Males were group-caged from weaning and subjected to repetitive handling stress; deterioration of glucose tolerance developed between 5 and 8 months of age in association with extreme hyperinsulinemia. Some males developed transient chemical diabetes in which plasma glucose concentrations were inappropriately high in relation to the high levels of plasma insulin. By 12 months of age, males previously glucose intolerant had regained a normal glucose tolerance. At death, a massive hypertrophy and hyperplasia of the islet beta-cells was documented in these mice. The impaired glucose tolerance could be circumvented by adrenalectomy at weaning. Although these finding suggested the presence of an obesity gene, the C3H.SW group-caged males were not obese when compared with C3HeB/FeJ males which, although moderately hyperinsulinemic, did not develop the glucose intolerance syndrome. Transfer of the Y chromosome from the C3HeB/FeChp background into the C3H.SW inbred background led to a reduction in the hyperinsulinemic and hyperglycemic stress on the pancreatic islets. Thus the extrinsic environment (caging and handling stress), mediated in part via the adrenal gland, could interact with sex-linked genetic susceptibility modifiers to stimulate hyperplasia of the pancreatic islets and produce a transient insulin resistant state of impaired glucose tolerance in the absence of obesity.